PATRICIA SANFORD: Open Payments
NPI 1063699924 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 28 payments from 10 companies in 2025. Trend: 2023 $454 · 2024 $826 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $110 |
| Gilead Sciences, Inc. | 4 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Janssen Biotech, Inc. | 2 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| QOL Medical, LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $16 |
Products named: ENTYVIO, RINVOQ, XIFAXAN, CREON, TREMFYA, ZENPEP, DUPIXENT, EOHILIA.
Industry payments across CO — which companies pay providers there.
